Ming-Lun Yeh Selected Research

Fetal Proteins (Fetoprotein)

1/2020	Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis B.
3/2018	Role of IL-28B genetic variants in HCV-related liver disease severity in patients with different viral genotypes.
1/2017	Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients.
3/2015	Association of diabetes and PNPLA3 genetic variants with disease severity of patients with chronic hepatitis C virus infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ming-Lun Yeh Research Topics

Disease

70	Chronic Hepatitis C 09/2022 - 11/2008
47	Infections 08/2022 - 04/2009
36	Hepatocellular Carcinoma (Hepatoma) 04/2022 - 02/2011
30	Fibrosis (Cirrhosis) 07/2022 - 01/2011
20	Chronic Hepatitis B 02/2022 - 01/2014
18	Hepatitis B 07/2022 - 01/2011
15	Neoplasms (Cancer) 02/2022 - 04/2008
15	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021 - 05/2011
13	Hepatitis C 01/2021 - 01/2013
8	Viremia 12/2021 - 01/2014
7	Hepatitis 07/2022 - 01/2014
7	Liver Diseases (Liver Disease) 11/2018 - 01/2013
5	Non-alcoholic Fatty Liver Disease 03/2022 - 03/2016
5	Fatty Liver 12/2021 - 07/2015
4	Chronic Renal Insufficiency 02/2022 - 04/2021
4	Disease Progression 01/2022 - 06/2017
3	Body Weight (Weight, Body) 07/2022 - 05/2015
3	Hypertension (High Blood Pressure) 01/2022 - 01/2020
3	Diabetes Mellitus 01/2022 - 07/2016
3	Coinfection 10/2021 - 01/2018
3	HIV Infections (HIV Infection) 10/2016 - 01/2014
2	Virus Diseases (Viral Diseases) 02/2022 - 09/2016
2	Hyperlipidemias (Hyperlipidemia) 01/2022 - 01/2021
2	Cryoglobulinemia 01/2022 - 11/2018
2	Chronic Kidney Failure (Chronic Renal Failure) 08/2021 - 01/2021
2	Reinfection 01/2021 - 01/2013
2	Hyperuricemia 03/2020 - 01/2018
2	Liver Failure 01/2020 - 01/2018
2	Insulin Resistance 05/2015 - 09/2011
2	Liver Neoplasms (Liver Cancer) 02/2015 - 07/2013
2	Wounds and Injuries (Trauma) 01/2011 - 11/2008
1	Glucose Intolerance 09/2022
1	Body Weight Changes 07/2022
1	Necrosis 03/2022
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2022
1	Autoimmune Hepatitis 01/2022
1	Inflammation (Inflammations) 10/2021
1	Alcoholic Fatty Liver 10/2021

Drug/Important Bio-Agent (IBA)

48	Antiviral Agents (Antivirals)IBA 09/2022 - 02/2011
23	Ribavirin (Virazole)FDA LinkGeneric 01/2022 - 08/2010
22	InterferonsIBA 01/2022 - 08/2010
17	RNA (Ribonucleic Acid)IBA 01/2022 - 05/2015
13	Hepatitis B Surface Antigens (HBsAg)FDA Link 12/2021 - 01/2011
8	Biomarkers (Surrogate Marker)IBA 04/2022 - 08/2010
8	Proteins (Proteins, Gene)FDA Link 03/2022 - 05/2011
8	Alanine Transaminase (SGPT)IBA 12/2021 - 05/2015
8	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 01/2011
6	Glucose (Dextrose)FDA LinkGeneric 09/2022 - 04/2009
6	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2022 - 02/2015
5	Sorafenib (BAY 43-9006)FDA Link 02/2022 - 10/2019
5	micaIBA 01/2019 - 12/2015
4	Hepatitis B e AntigensIBA 07/2022 - 04/2014
4	Tenofovir (Viread)FDA Link 07/2022 - 01/2020
4	Carrier Proteins (Binding Protein)IBA 03/2022 - 08/2017
4	entecavir FDA Link 02/2022 - 11/2016
4	Pharmaceutical PreparationsIBA 02/2022 - 01/2014
4	CytokinesIBA 01/2022 - 03/2011
4	nasIBA 10/2021 - 01/2019
4	Uric Acid (Urate)IBA 03/2020 - 01/2015
4	Fetal Proteins (Fetoprotein)IBA 01/2020 - 03/2015
3	wisteria lectinIBA 03/2022 - 08/2017
3	SofosbuvirIBA 02/2022 - 01/2021
3	BilirubinIBA 01/2022 - 10/2019
3	Interferon-alpha (Interferon Alfa)IBA 04/2021 - 01/2015
3	AntigensIBA 04/2021 - 11/2016
3	NucleosidesIBA 01/2021 - 11/2020
3	NucleotidesIBA 01/2021 - 11/2020
3	LipidsIBA 11/2020 - 05/2015
3	Phospholipases (Phospholipase)IBA 03/2016 - 03/2015
2	AutoantibodiesIBA 01/2022 - 06/2012
2	Transaminases (Aminotransferases)IBA 12/2021 - 01/2020
2	Insulin (Novolin)FDA Link 10/2021 - 05/2015
2	AlbuminsIBA 04/2021 - 01/2020
2	Indicators and Reagents (Reagents)IBA 01/2021 - 02/2019
2	asunaprevirIBA 01/2021 - 01/2020
2	daclatasvirIBA 01/2021 - 01/2020
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 01/2017
2	InterleukinsIBA 03/2018 - 04/2013
2	Peptides (Polypeptides)IBA 05/2017 - 12/2015
2	Hemoglobins (Hemoglobin)IBA 04/2017 - 04/2008
2	Lamivudine (Epivir)FDA Link 11/2016 - 04/2016
2	MicroRNAs (MicroRNA)IBA 03/2016 - 05/2014
1	sofosbuvir drug combination ledipasvirIBA 08/2022
1	tenofovir alafenamideIBA 07/2022
1	CollagenIBA 07/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2022
1	velpatasvirIBA 02/2022
1	ChemokinesIBA 01/2022
1	regorafenibIBA 01/2022
1	L 644711 (B-3(+))IBA 10/2021

Therapy/Procedure

52	Therapeutics 04/2022 - 08/2010
4	Renal Dialysis (Hemodialysis) 08/2021 - 01/2014
4	Liver Transplantation 06/2018 - 01/2013
2	Debridement 03/2022 - 03/2002
2	Laparotomy 09/2018 - 10/2017
2	Operative Surgical Procedures 09/2018 - 09/2006
2	Secondary Prevention 06/2017 - 12/2015
1	Colostomy 03/2022
1	Drug Therapy (Chemotherapy) 02/2022
1	Salvage Therapy 01/2022